SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Hirotaka Matsuo, Hiroyuki Tomiyama, Wataru Satake, Toshinori Chiba, Hiroyuki Onoue, Yusuke Kawamura, Akiyoshi Nakayama, Seiko Shimizu, Masayuki Sakiyama, Manabu Funayama, Kenya Nishioka, Toru Shimizu, Kenichi Kaida, Keiko Kamakura, Tatsushi Toda, Nobutaka Hattori, Nariyoshi Shinomiya, ABCG2 variant has opposing effects on onset ages of Parkinson's disease and gout, Annals of Clinical and Translational Neurology, 2015, 2, 3
  2. 2
    Andreas Puschmann, Laura Brighina, Katerina Markopoulou, Jan Aasly, Sun Ju Chung, Roberta Frigerio, Georgios Hadjigeorgiou, Sulev Kõks, Rejko Krüger, Joanna Siuda, Christian Wider, Theresa A. Zesiewicz, Demetrius M. Maraganore, Clinically meaningful parameters of progression and long-term outcome of Parkinson disease: An international consensus statement, Parkinsonism & Related Disorders, 2015,

    CrossRef

  3. 3
    Kelly Claire Simon, Shirley Eberly, Xiang Gao, David Oakes, Caroline M. Tanner, Ira Shoulson, Stanley Fahn, Michael A. Schwarzschild, Alberto Ascherio, Mendelian randomization of serum urate and parkinson disease progression, Annals of Neurology, 2014, 76, 6
  4. 4
    Isabel González-Aramburu, Pascual Sánchez-Juan, María Sierra, Eduardo Fernández-Juan, Coro Sánchez-Quintana, José Berciano, Onofre Combarros, Jon Infante, Serum uric acid and risk of dementia in Parkinson's disease, Parkinsonism & Related Disorders, 2014, 20, 6, 637

    CrossRef

  5. 5
    M. F. McCarty, J. J. DiNicolantonio, The cardiometabolic benefits of glycine: Is glycine an 'antidote' to dietary fructose?, Open Heart, 2014, 1, 1, e000103

    CrossRef